Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 340
Last updated 2018-08-28
Summary
The purpose of this study is to detect whole chromosome abnormalities in maternal blood.
Conditions
- Down Syndrome
- Edwards Syndrome
Interventions
- OTHER
-
Maternal Blood Draw
Maternal Blood Draw
Sponsors & Collaborators
-
Obstetrix Medical Group
collaborator INDUSTRY -
Progenity, Inc.
lead INDUSTRY
Principal Investigators
-
Richard Porreco, MD · Obstetrix Medical Group of Colorado
-
Thomas Garite, MD · Obstetrix Medical Group
Eligibility
- Min Age
- 18 Years
- Max Age
- 54 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2018-11-30
- Completion
- 2018-11-30
Countries
- United States
Study Locations
More Related Trials
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Whole Blood Specimen Collection From Pregnant Subjects
NCT02430584 ·Status: UNKNOWN
-
Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
NCT00006445 ·Status: UNKNOWN ·Phase: NA
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
NCT02787486 ·Status: COMPLETED
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
Automated Screen for Fetal Aneuploidy
NCT03635359 ·Status: UNKNOWN
-
Comparison of Aneuploidy Risk Evaluations
NCT01663350 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
NCT01708746 ·Status: COMPLETED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis
NCT01279733 ·Status: COMPLETED
-
An Interactive Informed Consent and Education Program for Pregnant Women
NCT01176019 ·Status: COMPLETED ·Phase: PHASE1